KEEP YOUR PATIENTS ON TRACK WITH TAKHZYRO
Long-term prevention. Long-term support.
TAKHZYRO has an established safety profile and effectiveness in patients 2 years of age and older.1
This was demonstrated in a 6.5-month study and a 2.5-month open-label extension study in patients ≥12 years and in a 12-month open-label study in patients 2 to ≤12.1
Takeda is here to support your patient's treatment journey for the long term, with 12+ years of experience treating and providing product support services for people with HAE.1,2
Help patients stay prepared to prevent HAE attacks
Encourage your patients to keep taking TAKHZYRO exactly as you prescribed. Although some patients may start to see results quickly, due to a half-life of ~14 days, it takes 6-10 doses (10 weeks) to reach steady state.1 Suggest these tips to help your patient initiate a routine and remember their dosing schedule:
-
Get alerts or reminders:
- Create a calendar event on their phone or computer with a notification alert that repeats every other week
- Sign up for the TAKHZYRO Text Reminder Program. They will get a text message the day before and the day of their scheduled dose. Tell them to visit TAKHZYRO.com or text SIGNUP (o RECORDAR en español) to 36395 to get started*
- Ask their loved ones for help. Ask a family member or friend to remind them when it’s time to take their TAKHZYRO
- Choose a dosing day that works best for their lifestyle. Think of something that will be easy to remember. For example, they could try "TAKHZYRO Tuesday"
*Message and data rates may apply. Average of 3 messages per month. Text HELP to 36395 for more information or text STOP to 36395 to end text reminders. View our Terms & Conditions at engagedrx.com/tak.
Remind your patients
why they started
taking TAKHZYRO
Continue to check in—reinforcing the impact effective prevention has had on their lives and their progress since starting TAKHZYRO.
HAE attacks can be unpredictable, debilitating, and even life-threatening. Your patient’s adherence to their HAE preventive treatment plan is the best way to help stay ahead of future attacks. Their next HAE attack may be nothing like their last, and it won’t be their last. That’s why it’s so important you remind them to keep taking TAKHZYRO as prescribed so they can continue to see improved outcomes and reimagine their life with HAE.
Considerations for the next check-in with
your patient
HAE is a lifelong condition, and it's important to set specific goals for therapy. Choosing TAKHZYRO may allow patients to achieve effective prevention of attacks for periods of time when treating this unpredictable disease. Important metrics to track as they progress toward their goals are:
- Your patient’s HAE attacks. What were their frequency and severity before preventive treatment and now?
- On-demand medication. How often does your patient use it since taking TAKHZYRO?
- Check for proper adherence. Is your patient taking TAKHZYRO exactly as prescribed and sticking with their dosing schedule?
You and your patient decided together to add TAKHZYRO as a preventive treatment to their management plan to fit their needs. These needs can change over time, so consider these other areas recommended by the HAEA as you revisit their plan:
- Any other health issues they may have
- The benefit of keeping a symptom and treatment tracker for review
A treatment tracker is a great tool that can help you and your patient see how their management plan is working. It can also help to identify triggers so you can work with your patient on how to avoid them. Triggers can include4:
- Stress
- Hormonal fluctuations
- Exhaustion
- Physical pressure
Personalized product support for patients every step of the way
Remind patients that OnePath® helps people who have been prescribed TAKHZYRO per the approved indication get access to their medication.
